ECG Devices Market Size & Share, by Product, Service {Product (Resting, Stress, Holter Monitors, Implantable Loop Recorders, Event Monitors, MCT Devices, Smart ECG Monitors), Software, Service}; Lead Type (12-, 5-, 3-, 6-, Single-lead); End-user (Hospitals, Clinics & Cardiac Centers, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4241
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Dominating the Global ECG Devices Landscape

top-features-companies
    • GE Healthcare

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • SCHILLER AG
    • Nihon Kohden Corporation
    • Ambu A/S
    • Medtronic plc
    • Koninklijke Philips
    • ACS Diagnostics
    • Hill-Rom Holdings
    • BPL Medical Technologies
    • BioTelemetry, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • GE Healthcare - AliveCor’s KardiaMobile personal electrocardiogram (ECG) device has been launched by GE Healthcare in partnership with AliveCor, to help patients to monitor their heart conditions from anywhere.

  •  Medtronic - Two AccuRhythm AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) has been given clearance by the U.S Food and Drug Administration (FDA) has announced by Medtronic. AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, and thereby improves the accuracy of information received by physicians, helping them to diagnose and treat abnormal heart rhythms in a more efficient way.

 

 


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4241
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of cardiovascular disease (CVDs) worldwide along with technological advancements in ECG devices are the major factors driving the growth of the ECG devices market.

The market is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023-2035.

Insufficient skilled personnel to operate ECG devices and strict regulatory standards for device approval are the challenges affecting the market growth.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are GE Healthcare, SCHILLER, Nihon Kohden Corporation, Ambu A/S,Medtronic, Koninklijke Philips, ACS Diagnostics, Hill-Rom Holdings, BPL Medical Technologies, and BioTelemetry, Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product and service, lead type, end user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying